297 related articles for article (PubMed ID: 18186718)
1. Trichomonas vaginalis in Vanuatu.
Fotinatos N; Warmington A; Walker T; Pilbeam M
Aust J Rural Health; 2008 Feb; 16(1):23-7. PubMed ID: 18186718
[TBL] [Abstract][Full Text] [Related]
2. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B
Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
[TBL] [Abstract][Full Text] [Related]
3. Sexually transmitted infections among pregnant women attending an antenatal clinic in Fuzhou, China.
Chen XS; Yin YP; Chen LP; Thuy NT; Zhang GY; Shi MQ; Hu LH; Yu YH
Sex Transm Dis; 2006 May; 33(5):296-301. PubMed ID: 16554698
[TBL] [Abstract][Full Text] [Related]
4. Estimates for cervical abnormalities in Vanuatu.
Fotinatos N; Warmington A; Walker T; Pilbeam M
Aust N Z J Public Health; 2007 Dec; 31(6):571-5. PubMed ID: 18081580
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for treating sexually transmitted infections and reducing HIV risk in rural South Africa.
Frohlich JA; Abdool Karim Q; Mashego MM; Sturm AW; Abdool Karim SS
J Adv Nurs; 2007 Nov; 60(4):377-83. PubMed ID: 17822425
[TBL] [Abstract][Full Text] [Related]
6. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
7. Sexually transmitted diseases and HIV/AIDS in Vanuatu: a cause for concern and action.
Zenner D; Russell S
N Z Med J; 2005 Aug; 118(1220):U1610. PubMed ID: 16132071
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.
Helms DJ; Mosure DJ; Metcalf CA; Douglas JM; Malotte CK; Paul SM; Peterman TA
Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314
[TBL] [Abstract][Full Text] [Related]
9. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania.
Klinger EV; Kapiga SH; Sam NE; Aboud S; Chen CY; Ballard RC; Larsen U
Sex Transm Dis; 2006 Dec; 33(12):712-8. PubMed ID: 16755271
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria.
Anorlu RI; Fagbenro Beyioku AF; Fagorala T; Abudu OO; Galadanci HS
Niger Postgrad Med J; 2001 Dec; 8(4):183-6. PubMed ID: 11922025
[TBL] [Abstract][Full Text] [Related]
11. Screening for sexually transmitted diseases in rural women in Papua New Guinea: are WHO therapeutic algorithms appropriate for case detection?
Passey M; Mgone CS; Lupiwa S; Tiwara S; Lupiwa T; Alpers MP
Bull World Health Organ; 1998; 76(4):401-11. PubMed ID: 9803591
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of depression among adults in Oyo State, Nigeria: a comparative study of rural and urban communities.
Amoran O; Lawoyin T; Lasebikan V
Aust J Rural Health; 2007 Jun; 15(3):211-5. PubMed ID: 17542795
[TBL] [Abstract][Full Text] [Related]
13. Trichomonas vaginalis infection among women in a low prevalence setting.
Uddin RN; Ryder N; McNulty AM; Wray L; Donovan B
Sex Health; 2011 Mar; 8(1):65-8. PubMed ID: 21371384
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.
Mavedzenge SN; Pol BV; Cheng H; Montgomery ET; Blanchard K; de Bruyn G; Ramjee G; Straten Av
Sex Transm Dis; 2010 Jul; 37(7):460-6. PubMed ID: 20562586
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
Van der Pol B
Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
[No Abstract] [Full Text] [Related]
16. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity?
Magnus M; Clark R; Myers L; Farley T; Kissinger PJ
Sex Transm Dis; 2003 Nov; 30(11):839-43. PubMed ID: 14603092
[TBL] [Abstract][Full Text] [Related]
17. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon.
Garcia A; Exposto F; Prieto E; Lopes M; Duarte A; Correia da Silva R
Int J STD AIDS; 2004 Sep; 15(9):615-8. PubMed ID: 15339370
[TBL] [Abstract][Full Text] [Related]
18. Trichomonas vaginalis: underdiagnosis in urban Australia could facilitate re-emergence.
Lusk MJ; Naing Z; Rayner B; Rismanto N; McIver CJ; Cumming RG; McGeechan K; Rawlinson WD; Konecny P
Sex Transm Infect; 2010 Jun; 86(3):227-30. PubMed ID: 19880969
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears.
Sardana S; Sodhani P; Agarwal SS; Sehgal A; Roy M; Singh V; Bhatnagar P; Murthy NS
Acta Cytol; 1994; 38(5):693-7. PubMed ID: 8091899
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of 4 agents of sexually transmitted diseases in leukorrhea in Abidjan (Ivory Coast)].
Faye-Kette YH; Kouassi AA; Sylla-Koko DF; Kacou-N'-Douba A; Akoua-Koffi G; Acho YB; Cisse L; Bouzid SA; Kouakou K; Dosso M
Bull Soc Pathol Exot; 1993; 86(4):245-7; discussion 247. PubMed ID: 8292912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
